睡眠对夜间脑脊液β淀粉样蛋白动力学的影响
研究通过腰穿导管连续采集脑脊液,比较睡眠剥夺、钠羟丁酸治疗和正常睡眠条件下β淀粉样蛋白动力学变化。所有受试者输注13C6-亮氨酸以测量β淀粉样蛋白生成速率。结果显示,与睡眠对照组相比,睡眠剥夺通过增加夜间β淀粉样蛋白生成,使β淀粉样蛋白38、40和42水平升高25%至30%。
要点
- 睡眠剥夺使夜间脑脊液β淀粉样蛋白38、40、42水平升高25%至30%。
- 升高机制为夜间β淀粉样蛋白生成增加,而非清除减少。
- disrupted sleep may increase Alzheimer disease risk via increased amyloid β production.
核心结论
- 睡眠剥夺通过增加夜间β淀粉样蛋白生成,使脑脊液β淀粉样蛋白38、40和42水平升高25%至30%,提示睡眠紊乱可能通过增加β淀粉样蛋白生成提高阿尔茨海默病风险。
研究设计与样本
- 人类研究,使用留置腰穿导管在受试者睡眠剥夺、钠羟丁酸治疗或正常睡眠时连续采集脑脊液。
- 所有受试者输注13C6-亮氨酸以测量β淀粉样蛋白动力学。
主要发现
- 与睡眠对照组相比,睡眠剥夺使夜间β淀粉样蛋白38、40和42水平升高25%至30%。
- 睡眠剥夺通过增加夜间β淀粉样蛋白生成导致上述水平升高。
临床怎么用
- 睡眠紊乱可能是阿尔茨海默病的可干预风险因素,改善睡眠或减少睡眠剥夺或有助于降低β淀粉样蛋白生成。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Sleep disturbances are associated with future risk of Alzheimer disease. Disrupted sleep increases soluble amyloid β, suggesting a mechanism for sleep disturbances to increase Alzheimer disease risk. We tested this response in humans using indwelling lumbar catheters to serially sample cerebrospinal fluid while participants were sleep-deprived, treated with sodium oxybate, or allowed to sleep normally. All participants were infused with 13 C6 -leucine to measure amyloid β kinetics. We found that sleep deprivation increased overnight amyloid β38, amyloid β40, and amyloid β42 levels by 25 to 30% via increased overnight amyloid β production relative to sleeping controls. These findings suggest that disrupted sleep increases Alzheimer disease risk via increased amyloid β production. Ann Neurol 2018;83:197-204.
引用
- Lucey BP, Hicks TJ, McLeland JS, et al. Effect of sleep on overnight cerebrospinal fluid amyloid β kinetics. Ann Neurol. 2018. PMID: 29220873. doi:10.1002/ana.25117
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。